Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Effects of ozone and nitrogen dioxide on human lung proteinase inhibitors. Research report, May 1983-January 1987

Technical Report ·
OSTI ID:6687054
This study investigated the usefulness of the oxidized forms of alpha-1-proteinase inhibitor (PI) and bronchial leukocyte proteinase inhibitor (BLPI) as in vivo markers for ozone (O/sub 3/) and nitrogen dioxide (NO/sub 2/) exposure. It was concluded that the existing assays were not sufficiently sensitive as markers of O/sub 3/ exposure. In vitro studies on the exposure of proteinase inhibitors to O/sub 3/ showed that despite their differing amino-acid compositions, they displayed similar kinetics of deactivation. While the amino acids (tryptophan, methionine, tyrosine, and histidine) were found to be most susceptible to oxidation, the absence of these did not affect the deactivation kinetics, nor did the presence of stabilizing disulfide bridges in BLPI provide increased protection against O/sub 3/. Free-radical scavengers offered more protection against oxidants than against antioxidants. The studies on NO/sub 2/ were incomplete. However, it appears that the mechanisms of action of O/sub 3/ and NO/sub 2/ are similar.
Research Organization:
Health Effects Inst., Cambridge, MA (USA)
OSTI ID:
6687054
Report Number(s):
PB-88-234422/XAB; HEI/RR-87/11
Country of Publication:
United States
Language:
English